Pharvaris N.V. cash flow to debt ratio of -17.65K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Pharvaris N.V.'s free cash flow has decreased 13.73% from $-120.67M last year to $-137.24M, signaling decreasing performance

Pharvaris N.V.'s debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Pharvaris N.V.'s debt has decreased relative to shareholder equity from 0.00 last year to 0.00 today, signaling strengthened financials

Pharvaris N.V. has negative EBITDA, making leverage ratio unreliable

Pharvaris N.V.'s interest coverage ratio is -1.97K, which means that the company struggles to meet interest obligations, signaling financial risk.

Pharvaris N.V. has insufficient data to evaluate this check.

Pharvaris N.V.'s short-term assets of $299.17M exceed its short-term liabilities of $29.60M

Pharvaris N.V.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Pharvaris N.V.'s return on equity of -67.40%, is lower than 15.00%, indicating bad performance

Pharvaris N.V.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Pharvaris N.V. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Pharvaris N.V. has negative free cash flow, indicating the company is burning cash rather than generating it

Pharvaris N.V. has negative free cash flow, indicating cash burn

Pharvaris N.V.'s yearly earnings has decreased 30.90% since last year from $-134.22M to $-175.70M, signaling decreasing performance

Pharvaris N.V.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -72.82% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Pharvaris N.V. has insufficient revenue history to calculate 3-year revenue CAGR.

Pharvaris N.V. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

Pharvaris N.V. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Pharvaris N.V. has insufficient data to evaluate this check.

Pharvaris N.V. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Pharvaris N.V. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Pharvaris N.V. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Pharvaris N.V. has insufficient data to evaluate this check.

Pharvaris N.V. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Pharvaris N.V. has a price-to-book ratio of 9.51x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Pharvaris N.V. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue